HOUSTON, TX–(Marketwired – Jan 12, 2015) – Nobilis Health Corp. (TSX: NHC) reports estimated revenues for the fourth quarter, 2014 of $39.2 million, an increase of $25.7 million or 190.0%, compared to $13.5 million from the fourth quarter of 2013.
Nobilis’ estimated annual revenue for 2014 is $83.6 million, an increase of $52.5 million or 168.5%, compared to $31.1 million from 2013.
“Our revenue forecasts of $30 million for the fourth quarter and $74 million for the year 2014 were exceeded, due in large part, to the effectiveness of our marketing programs,” said Harry Fleming, President. “We have forecast $205 million in revenue and $41 million in EBITDA for 2015. These forecasts do not anticipate acquisitions and are expected to come from our current operating assets,” said Fleming.
“Our integration plan is well under way following the November acquisition,” said Chris Lloyd, CEO. “With our marketing teams fully integrated at this point, we are in the process of rolling out combined marketing programs for several products in multiple cities,” continued Lloyd.
About Nobilis Health Corp.
Nobilis owns and manages ten healthcare facilities in Texas and Arizona; a surgical hospital (Houston), six ambulatory surgery centers, two MRI centers and an urgent care center. The six ambulatory surgery centers are located in Houston (three), Dallas (two) and Scottsdale, Arizona. Nobilis also has marketing relationships with 16 additional surgical centers across the US.
EBITDA is defined as earnings before interest, income taxes and depreciation and amortization. EBITDA should not be considered a measure of financial performance under generally accepted accounting principles. Items excluded from EBITDA are significant components in understanding and assessing financial performance. EBITDA is an analytical indicator used by management and the health care industry to evaluate company performance, allocate resources and measure leverage and debt service capacity. EBITDA should not be considered in isolation or as an alternative to net income, cash flows generated by operations, investing or financing activities, or other financial statement data presented in the consolidated financial statements as indicators of financial performance or liquidity. Because EBITDA is not a measurement determined in accordance with generally accepted accounting principles and is thus susceptible to varying calculations, EBITDA as presented may not be comparable to other similarly titled measures of other companies. Net income attributable to Nobilis Health Corp. common shareholders is the financial measure calculated and presented in accordance with generally accepted accounting principles that is most comparable to EBITDA as defined.
This news release may contain forward-looking statements (within the meaning of applicable securities laws) relating to business of Nobilis Health Corp. (the “Company”) and the environment in which it operates. Forward-looking statements are identified by words such as “believe”, “anticipate”, “expect”, “intend”, “plan”, “will”, “may” and other similar expressions. These statements are based on the Company’s expectations, estimates, forecasts and projections. They are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. These risks and uncertainties are discussed in the Company’s regulatory filings available on the Company’s web site at www.NobilisHealth.com or at www.sedar.com. There can be no assurance that forward-looking statements will prove to be accurate as actual outcomes and results may differ materially from those expressed in these forward-looking statements. Readers, therefore, should not place undue reliance on any such forward-looking statements. Further, a forward-looking statement speaks only as of the date on which such statement is made. The Company undertakes no obligation to publicly update any such statement or to reflect new information or the occurrence of future events or circumstances.